Thrombosis and Thromboembolism provides a comprehensive review of the most important changes and advances impacting the care of patients who have or are at risk for these afflictions. Education is provided by world-renowned experts and Harvard Medical School’s leading clinical faculty. The curriculum includes:

• New options for testing and diagnosis of thrombotic disorders
• Important developments in epidemiology and pathophysiology
• Best practices for stroke prevention (and prediction) in atrial fibrillation
• Guidance to navigate the nuances of prescribing dual antiplatelet therapy
• When and how to use new oral anticoagulants and interventional devices
• Personalized medicine and lipid biology
• Updated lipid guidelines (and controversies surrounding them)
• Expert advice to incorporate the latest science into your practice

Thrombosis and Thromboembolism has provided practical and timely education about innovations in this field since 1987. First-time and returning attendees consistently report that the knowledge they acquire from this update changes their practice and drives better outcomes for patients.

Attendees stay current with the state of the art for:

• DVT/PE diagnosis and testing
• Parenteral and oral anticoagulants
• Genetics, thrombosis, and personalized medicine
• Atherothrombosis: etiology, pathophysiology, therapy
• Hypercoagulability: testing and management
• Management of chronic venous insufficiency
• Pharmacomechanical therapy
• Utilization of the vascular diagnostic laboratory
• Lipid management (and new guidelines)
• Dual antiplatelet therapy: dose, duration, reversibility
• Detecting atrial fibrillation after stroke
• Special considerations for VTE in cancer and pregnancy

This program is among the highest-rated Harvard Medical School CME courses.

Please note that this course is only offered once every three years, and seating is limited. To ensure a spot, early registration is strongly recommended.